Sedicidodici
Pordenone
About Sedicidodici
Sedicidodici they provide tool for measuring the haemorrhagic and thrombogenic potential “ex vivo” of patients affected by cardiovascular diseases and thrombotic-haemorrhagic disorders, and for monitoring the effects of anticoagulation and antiplatelet drug therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Funding stage: Seed
- Last round: Grant (Aug 2018)
- Website: sedicidodici.com
- Phone: 390434504410
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sedicidodici-2241554 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.